
Enzymes (Second Edition)
.pdf260 EXPERIMENTAL MEASURES OF ENZYME ACTIVITY
Even with low protein binding materials, one will still experience losses of protein due to adsorption. To minimize these effects, it is often possible to add a carrier protein to enzyme samples, as long as it has been established that the carrier protein does not interfere with the enzyme assay in any way. A carrier protein is an inert protein that is added to the enzyme solution at much higher concentrations than that of the enzyme. In this way potential protein binding surfaces will be saturated with the carrier protein, hence are not available for adsorption of the enzyme of interest. It is a very common practice among enzymologists to add carrier proteins to the enzyme stock solutions and to the final reaction mixtures. Bovine serum albumin (BSA), gelatin, and casein are commonly used proteins for this purpose. Our laboratory has found that gelatin, at a concentration of 1 mg/mL, is a particularly good carrier protein for many enzymes. The lack of aromatic amino acids in the gelatin makes this a useful carrier protein for enzyme studies utilizing ultraviolet absorption or fluorescence spectroscopy. Gelatin, casein, and BSA are available commercially in highly purified forms from a number of suppliers.
Some workers have found polyethylene glycol, molecular weight 8000 Da (PEG-8000), to be a useful alternative to carrier proteins for minimizing enzyme adsorption to container surfaces (Andrew M. Stern, personal communication). Addition of PEG-8000 to 0.1% has been used in this regard for a number of enzymes. If PEG-8000 is to be used for this application, a high grade (i.e., molecular biology grade or the equivalent) should be used, since lower grades of PEGs may contain impurities that can have deleterious effects on enzyme activity. Our own experience with the use of PEG-8000 suggests that this additive works well to stabilize some, but not all, enzyme activities. Hence, again, the reader is left to explore the utility of this approach on a case-by-case basis.
7.6.2 Enzyme Inactivation During Activity Assays
Certain enzymes that are stable under optimized conditions of long-term storage (as just described) will inactivate during the course of an activity assay. This behavior is characterized by progress curves that plateau early, before significant substrate loss has occurred (see Section 7.1.2 for other causes of this behavior). There are two common reasons for this type of enzyme inactivation. First, the active conformation of the enzyme may not be stable under the specific conditions (i.e., temperature, pH, ionic strength, and dilution of enzyme concentration) used in the assay. For example, if the active form of the enzyme is a dimer, dilution to low concentration at the initiation of an activity assay may cause simultaneous dissociation of the dimeric enzyme to monomers. If the time course of dimer dissociation is slow, hence similar to that of the enzymatic assay, a diminution of activity may be seen over the time course of the activity measurements. Sometimes minor adjustments in final enzyme
ENZYME STABILITY |
261 |
concentration can help to ameliorate this situation. Likewise, minor adjustments in other solution conditions can help to extend the lifetime of the active enzyme species during activity assays. For multisubstrate enzymes (see Chapter 11), the stability of the enzyme can sometimes also be greatly augmented by preforming a binary enzyme—substrate complex and initiating the reaction by addition of a second substrate.
The second cause of activity loss during assay is spontaneous enzyme inactivation that results directly from catalytic turnover. For some enzymes, the chemistry associated with turnover can lead to inactivation of the enzyme by covalent adduct formation, or by destruction of a key active site amino acid residue or cofactor. For example, some oxidoreductases form highly damaging free radical species as a by-product of their catalytic activity. When this occurs, the radicals that build up during turnover can attack the enzyme active site, rendering it inactive. In these cases, the radical-based inactivation can sometimes be minimized by the addition of free radical scavengers, such as phenol, to the reaction mixture. Addition of a small amount of a peroxidase enzyme, such as catalase, can also sometimes help to stabilize the enzyme of interest from radical-based inactivation. Of course, it is critical to determine that addition of such species does not affect the measurement of enzyme activity in other ways.
Regardless of the cause, enzyme inactivation during activity assays can be diagnosed by two simple tests. The first test is to allow the progress curve to go to its premature plateau and then add a small volume of additional enzyme stock that would double the final enzyme concentration in the reaction mixture (i.e., addition of a mass of enzyme equal to the initial enzyme mass in the reaction mixture). If enzyme inactiviation during the assay is the cause of the premature plateau, a second phase of reaction should be realized after the addition of the second volume of fresh enzyme.
The second test, known as Selwyn’s test (Selwyn, 1965), consists of measuring the reaction progress curve at several different concentrations of enzyme. The test makes use of the fact that regardless of its complexity for individual enzymatic reactions, the integrated rate equation has the general form:
[E]t f ([P]) |
(7.23) |
when all other conditions are held constant. Hence the concentration of product, [P] is some constant function of the multiplicative product of enzyme concentration and assay time. The term [E] in Equation 7.23 refers to the concentration of active enzyme molecules in solution. If the enzyme is stable over the course of the assay, a plot of [P] as a function of [E]t should give superimposable curves at all concentrations of enzyme (Figure 7.31A). If, however, the enzyme is undergoing unimolecular inactivation during the course of the activity assay, the concentration of active enzyme will itself show a first-order time dependence. Thus, the dependence of [P] on [E] will have

262 EXPERIMENTAL MEASURES OF ENZYME ACTIVITY
Figure 7.31 Selwyn’s test for enzyme inactivation during an assay. (A) Data at several enzyme concentrations for an enzyme that is stable during the assay time course. Note that the data for different enzyme concentrations (represented by different symbols on the graph) are well fit by a single curve. (B) Corresponding data for an enzyme that undergoes inactivation during the course of the activity assay; the data for different enzyme concentrations cannot be
fit by a single curve.
the more complex form of Equation 7.24:
[P] |
k[E] |
(1 e ) |
(7.24) |
|
where k is a constant of proportionality and is the first-order decay constant for enzyme inactivation. Now plots of [P] as a function [E]t will vary with changing enzyme concentration (Figure 7.31B). The lack of superposition of
REFERENCES AND FURTHER READING |
263 |
the data plots, as seen in Figure 7.31B, is a clear indication that enzyme inactivation has occurred during the assay time period.
7.7 SUMMARY
In this chapter we have presented an overview of some of the common methodologies for obtaining initial velocity measurements of enzymatic reactions. The most common detection methods and techniques for separating substrate and product molecules after reaction were discussed. We saw that changes in reaction conditions, such as pH and temperature, can have dramatic effects on enzymatic reaction rate. We saw further that controlled changes in these conditions can be used to obtain mechanistic information about the enzyme of interest. Finally, some advice was provided for the proper storage and handling of enzymes to optimally maintain their catalytic activity in the laboratory.
REFERENCES AND FURTHER READING
Bender, M. L., Kezdy, F. J., and Wedler, F. C. (1967) J. Chem. Educ. 44, 84.
Blacklow, S. C., Raines, R. T., Lim, W. A., Zamore, P. D., and Knowles, J. R. (1988)
Biochemistry, 27, 1158.
Cleland, W. W. (1979) Anal. Biochem. 99, 142.
Cleland, W. W., O’Leary, M. H., and Northrop, D. B. (1977) Isotope Effects on Enzyme-Catalyzed Reactions, University Park Press, Baltimore.
Copeland, R. A. (1994) Methods for Protein Analysis: A Practical Guide to L aboratory Protocols, Chapman & Hall, New York.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., and Trzaskos, J. M. (1994) Proc. Natl. Acad. Sci. USA 91, 11202.
Copeland, R. A., Lombardo, D., Giannaras, J., and Decicco, C. P. (1995) Bioorg. Med. Chem. L ett. 5, 1947.
Cornish-Bowden, A. (1972) Biochem. J. 130, 637.
Dixon, M., and Webb, E. C. (1979) Enzymes, 3rd ed., Academic Press, New York.
Duggleby, R. G. (1985) Biochem. J. 228, 55.
Duggleby, R. G. (1994) Biochim. Biophys. Acta, 1205, 268.
Duggleby, R. G., and Morrison, J. F. (1977) Biochim. Biophys. Acta, 481, 297.
Easterby, J. S. (1973) Biochim. Biophys. Acta, 293, 552.
Eisenthal, R., and Danson, M. J., Eds. (1992) Enzyme Assays, A Practical Approach, IRL Press, Oxford.
Fersht, A. (1985) Enzyme Structure and Function, 2nd ed., Freeman, New York.
Fletcher, A. N. (1969) Photochem. Photobiol. 9, 439.
Gabriel, O., and Gersten, D. M. (1992) In Enzyme Assays, A Practical Approach, R. Eisenthal and M. J. Danson, Eds., IRL Press, Oxford, pp. 217—253.
264 EXPERIMENTAL MEASURES OF ENZYME ACTIVITY
Gomori, G. (1992) In CRC Practical Handbook of Biochemistry and Molecular Biology, G. D. Fasman, Ed., CRC Press, Boca Raton, FL, pp. 553—560.
Hames, B. D., and Rickwood, D. (1990) Gel Electrophoresis of Proteins: A Practical Approach, 2nd ed., IRL Press, Oxford.
Hancock, W. S. (1984) Handbook of HPL C Separation of Amino Acids, Peptides, and Proteins, CRC Press, Boca Raton, FL.
Harlow, E., and Lane, D. (1988) Antibodies: A L aboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Haupt, G. W. (1952) J. Res. Natl. Bur. Stand. 48, 414.
Ittarat, I., Webster, H. K., and Yuthavong, Y. (1992) J. Chromatography, 582, 57.
Kellershohn, N., and Laurent, M. (1985) Biochem. J. 231, 65.
Knight, C. G. (1995) Methods Enzymol. 248, 18—34.
Knight, C. G., Willenbrock, F., and Murphy, G. (1992) FEBS Lett. 296, 263.
Kyte, J. (1995) Mechanisms in Protein Chemistry, Garland, New York.
Lackowicz, J. R. (1983) Principles of Fluorescence Spectroscopy, Plenum Press, New
York.
Matayashi, E. D., Wang, G. T., Krafft, G. A., and Erickson, J. (1990) Science, 247, 954.
Mozhaev, V. V., Berezin, I. V., and Martinek, K. (1987) Methods Enzymol. 135, 586.
Northrop, D. B. (1975) Biochemistry, 14, 2644.
Oldham, K. G. (1968) Radiochemical Methods of Enzyme Analysis, Amersham International, Amersham, U.K.
Oldham, K. G. (1977) In Radiotracer Techniques and Applications, Vol. 2, E. A. Evans and M. Muramatsu, Eds., Dekker, New York, pp. 823—891.
Oldham, K. G. (1992) In Enzyme Assays, A Practical Approach, R. Eisenthal and M. J. Danson, Eds., IRL Press, Oxford, pp. 93—122.
Oliver, R. W. (1989) HPLC of Macromolecules: A Practical Approach, IRL Press,
Oxford.
Packard, B. Z., Toptygin, D. D., Komoriya, A., and Brand, L. (1997) Methods Enzymol. 278, 15—28.
Palmer, T. (1985) Understanding Enzymes, Wiley, New York.
Purich, D. L., Ed. (1996) Contemporary Enzyme Kinetics and Mechanisms, 2nd ed., Academic Press, San Diego, CA.
Roughton, F. J. W., and Chance, B. (1963) In Techniques of Organic Chemistry, Vol. VIII, Part II, Investigation of Rates and Mechanisms of Reactions, S. L. Friess, E. S. Lewis, and A. Weissberger, Eds., Wiley, New York, pp. 703—792.
Rudolph, F. B., Baugher, B. W., and Beissmer, R. S. (1979) Methods Enzymol. 63, 22.
Russo, S. F. (1969) J. Chem. Educ. 46, 374.
Schonbaum, G. R., Zerner, B., and Bender, M. L. (1961) J. Biol. Chem. 236, 2930.
Schowen, K. B., and Schowen, R. L. (1982) Methods Enzymol. 87, 551.
Segel, I. H. (1976) Biochemical Calculations, 2nd ed., Wiley, New York.
Selwyn, M. J. (1965) Biochim. Biophys. Acta, 105, 193.
Silverman, R. B. (1988) Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology, Vols. I and II, CRC Press, Boca Raton, FL.
REFERENCES AND FURTHER READING |
265 |
Storer, A. C., and Cornish-Bowden, A. (1974) Biochem. J. 141, 205.
Tipton, K. F. (1992) In Enzyme Assays, A Practical Approach, R. Eisenthal and M. J. Danson, Eds., IRL Press, Oxford, pp. 1—58.
Tsukada, H., and Blow, D. M. (1985) J. Mol. Biol. 184, 703.
Venkatasubban, K. S., and Schowen, R. L. (1984) CRC Crit. Rev. Biochem. 17, 1. Waley, S. G. (1982) Biochem. J. 205, 631.

Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis.
Robert A. Copeland Copyright 2000 by Wiley-VCH, Inc.
ISBNs: 0-471-35929-7 (Hardback); 0-471-22063-9 (Electronic)
8
REVERSIBLE INHIBITORS
The activity of an enzyme can be blocked in a number of ways. For example, inhibitory molecules can bind to sites on the enzyme that interfere with proper turnover. We encountered the concept of substrate and product inhibition in Chapters 5, 6, and 7. For product inhibition, the product molecule bears some structural resemblance to the substrate and can thus bind to the active site of the enzyme. Product binding blocks the binding of further substrate molecules. This form of inhibition, in which substrate and inhibitor compete for a common enzyme species, is known as competitive inhibition. Perhaps less intuitively obvious are processes known as noncompetitive and uncompetitive inhibition, which define inhibitors that bind to distinct enzyme species and still block turnover. In this chapter, we discuss these varied modes of inhibiting enzymes and examine kinetic methods for distinguishing among them.
There are several motivations for studying enzyme inhibition. At the basic research level, inhibitors can be useful tools for distinguishing among different potential mechanisms of enzyme turnover, particularly in the case of multisubstrate enzymes (see Chapter 11). By studying the relative binding affinity of competitive inhibitors of varying structure, one can glean information about the active site structure of an enzyme in the absence of a high resolution three-dimensional structure from x-ray crystallography or NMR spectroscopy. Inhibitors occur throughout nature, and they provide important control mechanisms in biology. Associated with many of the proteolytic enzymes involved in tissue remodeling, for example, are protein-based inhibitors of catalytic action that are found in the same tissue sources as the enzymes themselves. By balancing the relative concentrations of the proteases and their inhibitors, an organism can achieve the correct level of homeostasis. Enzyme inhibitors have a number of commercial applications as well. For example,
266

STRUCTURE—ACTIVITY RELATIONSHIPS AND INHIBITOR DESIGN |
267 |
enzyme inhibitors form the basis of a number of agricultural products, such as insecticides and weed killers of certain types. Inhibitors are extensively used to control parasites and other pest organisms by selectively inhibiting an enzyme of the pest, while sparing the enzymes of the host organism. Many of the drugs that are prescribed by physicians to combat diseases function by inhibiting specific enzymes associated with the disease process (see Table 1.1 for some examples). Thus, enzyme inhibition is a major research focus throughout the pharmaceutical industry.
Inhibitors can act by irreversibly binding to an enzyme and rendering it inactive. This typically occurs through the formation of a covalent bond between some group on the enzyme molecule and the inhibitor. We shall discuss this type of inhibition in Chapter 10. Also, some inhibitors can bind so tightly to the enzyme that they are for all practical purposes permanently bound (i.e., their dissociation rates are very slow). These inhibitors, which form a special class known as tight binding inhibitors, are treated separately, in Chapter 9. In their most commonly encountered form, however, inhibitors are molecules that bind reversibly to enzymes with rapid association and dissociation rates. Molecules that behave in this way, known as classical reversible inhibitors, serve as the focus of our attention in this chapter.
Much of the basic and applied use of reversible inhibitors relies on their ability to bind specifically and with reasonably high affinity to a target enzyme. The relative potency of a reversible inhibitor is measured by its binding capacity for the target enzyme, and this is typically quantified by measuring the dissociation constant for the enzyme—inhibitor complex:
[E] [I] [EI]
K [E][I][EI]
The concept of the dissociation constant as a measure of protein—ligand interactions was introduced in Chapter 4. In the particular case of enzyme— inhibitor interactions, the dissociation constant is often referred to also as the inhibitor constant and is given the special symbol K . The K value of a reversible enzyme inhibitor can be determined experimentally in a number of ways. Experimental methods for measuring equilibrium binding between proteins and ligands, discussed in Chapter 4, include equilibrium dialysis, and chromatographic and spectroscopic methods. New instrumentation based on surface plasmon resonance technology (e.g., the BIAcore system from Pharmacia Biosensor) also allows one to measure binding interactions between ligands and macromolecules in real time (Chaiken et al., 1991; Karlsson, 1994). While this method has been mainly applied to determining the binding affinities for antigen—antibody and receptor—ligand interactions, the same technology holds great promise for the study of enzyme—ligand interactions as well. For example, this method has already been used to study the interactions between

268 REVERSIBLE INHIBITORS
protein-based protease inhibitors and their enzyme targets (see, e.g., Ma et al., 1994). Although these and many other physicochemical methods have been applied to the determination of K values for enzyme inhibitors, the most common and straightforward means of assessing inhibitor binding consists of determining its effect on the catalytic activity of the enzyme. By measuring the diminution of initial velocity with increasing concentration of the inhibitor, one can find the relative concentrations of free enzyme and enzyme—inhibitor complex at any particular inhibitor concentration, and thus calculate the relevant equilibrium constant. For the remainder of this chapter, we shall focus on the determination of K values through initial velocity measurements of these types.
8.1 EQUILIBRIUM TREATMENT OF REVERSIBLE INHIBITION
To understand the molecular basis of reversible inhibition, it is useful to reflect upon the equilibria between the enzyme, its substrate, and the inhibitor that can occur in solution. Figure 8.1 provides a generalized scheme for the potential interactions between these molecules. In this scheme, K is the equilibrium constant for dissociation of the ES complex to the free enzyme and the free substrate, K is the dissociation constant for the EI complex, and k is the forward rate constant for product formation from the ES or ESI complexes. The factor reflects the effect of inhibitor on the affinity of the enzyme for its substrate, and likewise the effect of the substrate on the affinity of the enzyme for the inhibitor. The factor reflects the modification of the rate of product formation by the enzyme that is caused by the inhibitor. An inhibitor that
Figure 8.1 Equilibrium scheme for enzyme turnover in the presence and absence of an inhibitor.
STRUCTURE—ACTIVITY RELATIONSHIPS AND INHIBITOR DESIGN |
269 |
completely blocks enzyme activity will have equal to zero. An inhibitor that only partially blocks product formation will be characterized by a value of between 0 and 1. An enzyme activator, on the other hand, will provide a value of greater than 1.
The question is often asked: Why is the constant the same for modification of K and K ? The answer is that this constant must be the same for both on thermodynamic grounds. To illustrate, let us consider the following set of coupled reactions:
E S ES |
G RT ln(K ) |
(8.1) |
|
|
|
ES I ESI |
G RT ln( K ) |
(8.2) |
|
|
|
The net reaction of these two is: |
|
|
E S I ESI |
G RT ln( K K ) |
(8.3) |
Now consider two other coupled reactions: |
|
|
E I EI |
G RT ln(K ) |
(8.4) |
EI S ESI |
G RT ln(aK ) |
(8.5) |
|
|
|
The net reaction here is: |
|
|
E S I ESI |
G RT ln(aK K ) |
(8.6) |
Both sets of coupled reactions yield the same overall net reaction. Since, as we reviewed in Chapter 2, G is a path-independent function, it follows that Equations 8.3 and 8.6 have the same value of G. Therefore:
RT ln( K K ) RT ln(aK K ) |
(8.7) |
(K K ) a(K K ) |
(8.8) |
a |
(8.9) |
Thus, the value of is indeed the same for the modification of K by inhibitor and the modification of K by substrate.
The values of and provide information on the degree of modification that one ligand (i.e., substrate or inhibitor) has on the binding of the other ligand, and they define different modes of inhibitor interaction with the enzyme.